Impax declares the launch of generic version of Solodyn

Read more

Laura Ames named CEO of Recovery Centers of America

Read more

Mylan N.V sought approval from FDA for NDA for Dolutegravir Tablets

Read more

Achieve declares preliminary data from Phase I/II PK/PD study of cytisine

Read more

Kancera AB imparts positive results from Phase I Study for KAND567

Read more

FDA quells PTC Therapeutic’s appeal for NDA for ataluren

Read more

Catheter Precision rolls out Clinical Trial for VIVO Non- Invasive Mapping system

Read more

Alcyone Lifesciences demarcates its Hydrocephalus business

Read more

Micromedic Technologies publishes triumphant Clinical Study results for detecting prostate cancer cells

Read more

PharmaJet collaborates with Genexine to commercialize DNA Vaccines

Read more